The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.
May 17, 2025
0
588
Learning about one's risk for Alzheimer's disease may not lead to emotional distress, but motivation to maintain healthy lifestyle changes tends to fade over time, even in people at high risk, according to a study involving ...
May 7, 2025
0
52
A new study conducted at Cedars-Sinai reveals how the cholesterol-reducing drug evolocumab prevents heart attacks in people with coronary artery disease—a leading cause of death in the United States.
May 6, 2025
0
38
Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS).
Apr 29, 2025
0
233
UC Davis Health's first-of-its-kind total body scanner EXPLORER is being given yet another new assignment—assessing how cancer, neurodegenerative diseases and other systemic conditions, can affect the brain.
Apr 23, 2025
0
28
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, ...
Apr 17, 2025
0
26
Music can evoke intense pleasure, sometimes experienced physically as pleasant "chills." While the effect of music on pleasure is clear, the brain mechanisms behind musical enjoyment are not yet fully understood. The brain's ...
Apr 16, 2025
0
235
A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a study by researchers at Washington University ...
Mar 31, 2025
0
1173
A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of Nuclear Medicine. The first-in-human study, which ...
Mar 28, 2025
0
21
A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's disease—in the brains of women over the age of 70 who took menopausal hormone therapy (HT) more than a decade ...
Mar 5, 2025
0
39
